CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC

CONSORT diagram. a Patients who had surgery; b Patients with

Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy

Cancers, Free Full-Text

Joseph P Costantino's research works

A Randomized Controlled Phase 2 Study of Neoadjuvant Eribulin Versus Paclitaxel in Women with Operable Breast Cancer: The JONIE-3 Study - Clinical Breast Cancer

Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative - European Journal of Cancer

Comparison of Rehabilitation Training at Different Timepoints to

National Surgical Adjuvant Breast and Bowel Project (NSABP)

Cancers, Free Full-Text

Nab-paclitaxel weekly versus dose-dense solvent-based paclitaxel followed by dose-dense epirubicin plus cyclophosphamide in high-risk HR+/HER2− early breast cancer: results from the neoadjuvant part of the WSG-ADAPT-HR+/HER2− trial - ScienceDirect